These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2113708)

  • 21. [Comparative analysis of the effects to date of the prevention of Rh incompatibility].
    Jedwabny A; Suchocki S; Bobrowska G
    Acta Haematol Pol; 1988; 19(1-2):56-8. PubMed ID: 2853507
    [No Abstract]   [Full Text] [Related]  

  • 22. [Infection risk factors in newborn infants with fetal erythroblastosis].
    Maszkiewicz W; Ornat K; Laskowska B; Irzyńska D; Manerowska D
    Acta Haematol Pol; 1988; 19(3-4):230-8. PubMed ID: 3150899
    [No Abstract]   [Full Text] [Related]  

  • 23. [Perinatal hemolytic disease caused by anti-c. A clinical case].
    Donoso Siña E; Herrera Gonzalez B; González Bruzzone P; Cuellar Castañón A
    Rev Chil Obstet Ginecol; 1983; 48(3):175-9. PubMed ID: 6442780
    [No Abstract]   [Full Text] [Related]  

  • 24. [Rhesus immunization in a rhesus-positive pregnant woman: fetal erythroblastosis caused by the rhesus antibody anti-C].
    Konstantin-Hansen KF; Larsen HL; Hejl M
    Ugeskr Laeger; 1989 Jun; 151(24):1553. PubMed ID: 2506685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of the degree of fetal injury by the Rh antibody titer in the amniotic fluid].
    Vitanova R
    Akush Ginekol (Sofiia); 1985; 24(1):43-7. PubMed ID: 3925801
    [No Abstract]   [Full Text] [Related]  

  • 26. Haemolytic disease of the newborn.
    Lancet; 1989 Feb; 1(8634):361-2. PubMed ID: 2563513
    [No Abstract]   [Full Text] [Related]  

  • 27. [Two cases of unusual allo-immunization caused by atypical antibodies].
    Le Vaillant C; Jacopin-Bruneau L; Nowak C; Riteau AS
    Presse Med; 2015 Oct; 44(10):1078-82. PubMed ID: 26319768
    [No Abstract]   [Full Text] [Related]  

  • 28. [Incidence of Rh and ABO in hemolytic disease of newborn from 1979 to the present day in infants born at the Obstetrics Clinic of the II College of Medicine and Surgery of Naples].
    Cascioli CF; Longo G; Capasso A; Grisolia G; Apicella C; Capasso A; Tarabuso A; Liguori G
    Minerva Ginecol; 1985 Mar; 37(3):85-8. PubMed ID: 3927200
    [No Abstract]   [Full Text] [Related]  

  • 29. Noninvasive fetal Rh genotyping: the time has come.
    Queenan JT
    Obstet Gynecol; 2005 Oct; 106(4):682-3. PubMed ID: 16199621
    [No Abstract]   [Full Text] [Related]  

  • 30. [Blood group incompatible pregnancy].
    Suzuki M; Okubo M; Maeda H
    Nihon Rinsho; 1999 Nov; 57 Suppl():645-8. PubMed ID: 10635938
    [No Abstract]   [Full Text] [Related]  

  • 31. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of the Center for Rh-negative Mothers. Hospital Paula Jaraquemada (3 years)].
    Krug A; Bianchi R; Pérez N; Ilabaca G; Farías S; Rojas E
    Rev Chil Obstet Ginecol; 1981; 46(4):206-14. PubMed ID: 6099901
    [No Abstract]   [Full Text] [Related]  

  • 33. Perinatal management of fetal hemolytic disease due to Rh incompatibility combined with fetal alloimmune thrombocytopenia due to HPA-5b incompatibility.
    Schild RL; Hoch J; Plath H; Geissen C; Fahnenstich H; Dame C; Hansmann M
    Ultrasound Obstet Gynecol; 1999 Jul; 14(1):64-7. PubMed ID: 10461341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current aspects of fetomaternal immunizations].
    Dupont S; Ruf H; Blanc B; Adrai J; Conte M; Delpont PJ; Chau C
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):689-93. PubMed ID: 3936153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Spectrophotometric characteristics of the amniotic fluid in Rh isoimmunization following intrauterine fetal blood transfusions].
    Matrova TS; Vasileva Iu
    Akush Ginekol (Sofiia); 1989; 28(1):30-2. PubMed ID: 2500862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [15 years of Rh-immunization prevention program].
    Eklund J; Nevanlinna HR
    Katilolehti; 1984; 89(8):284-7. PubMed ID: 6441856
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of severe red cell immunization in pregnancy.
    Kanhai HH
    Eur J Obstet Gynecol Reprod Biol; 1991 Dec; 42 Suppl():S90-5. PubMed ID: 1809617
    [No Abstract]   [Full Text] [Related]  

  • 38. Severe hemolytic disease of the newborn from anti-e.
    McAdams RM; Dotzler SA; Winter LW; Kerecman JD
    J Perinatol; 2008 Mar; 28(3):230-2. PubMed ID: 18309317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe hemolytic disease of the newborn due to anti-c.
    Appelman Z; Lurie S; Juster A; Borenstein R
    Int J Gynaecol Obstet; 1990 Sep; 33(1):73-5. PubMed ID: 1974537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intrauterine rhesus diagnosis].
    Herrmann U
    Beitr Infusionsther; 1989; 24():214-20. PubMed ID: 2481541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.